Zobrazeno 1 - 10
of 11
pro vyhledávání: ''
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-11 (2021)
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-11 (2021)
Allergic rhinitis (AR) is the most common undiagnosed chronic condition in children. Moderate/severe AR symptoms significantly impair quality of life, and cause sleep disruption, absenteeism and decreased productivity. Additionally, untreated AR pred
Autor:
Koichi Jingo, Jun Ito, Toshihiko Nishioki, Haruhi Takagi, Tomohito Takeshige, Kazuhisa Takahashi, Norihiro Harada, Tomoko Yamada, Tetsuhiko Asao, Masahiro Torasawa
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-6 (2020)
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-6 (2020)
Background Omalizumab, mepolizumab, benralizumab, and dupilumab are the currently available biologics used to treat asthma in Japan. Anaphylaxis following treatment with mepolizumab or benralizumab is considered rare. Case presentation We report the
Autor:
Richard F. Lockey, Mathew Varghese
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 4, Iss 2, Pp 75-83 (2008)
Allergy, Asthma & Clinical Immunology, Vol 4, Iss 2, Pp 75-83 (2008)
This review focuses on aspirin-exacerbated asthma (AEA). The review includes historical perspective of aspirin, prevalence, pathogenesis, clinical features and treatment of AEA. The pathogenesis of AEA involves the cyclooxygenase and lipooxygenase pa
Autor:
Ronald A. Simon, Annie V Le
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 2, Iss 3, Pp 109-116 (2006)
Allergy, Asthma & Clinical Immunology, Vol 2, Iss 3, Pp 109-116 (2006)
With the judicious use of inhaled corticosteroids, β2 agonists, and leukotriene modifiers, most patients with asthma are easily controlled and managed. However, approximately 5% of asthmatics do not respond to standard therapy and are classified as
Autor:
Tiffany Wong, Sara Leo, Angela Alexander, Edmond Chan, Timothy Teoh, Joanne Yeung, John M. Dean, Ingrid Baerg, Kyla J. Hildebrand
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background Barriers to administering epinephrine auto injectors include failure to recognize signs and symptoms of anaphylaxis, administering oral antihistamines or asthma inhalers due to lack of education, failing to administer epinephrine correctly
Autor:
Diana Pham, William H. Yang, Stephanie Santucci, Ian MacLusky, Joseph Reisman, John W. O'Quinn, Zave Chad
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background In Canada and the US, omalizumab is indicated for adults and adolescents (>12 years of age) with moderate to severe persistent allergic asthma. In the EU, omalizumab has been approved for children (age 6 – 11 years) since 2009. The pedia
Autor:
Mariam Hanna, Douglas P. Mack
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
With emerging cases of adrenal suppression being reported in pediatric patients, finding appropriate steroid sparing agents is of clinical importance. Tiotropium bromide (TB), a long-acting anticholinergic, has recently been investigated in adults as
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background The efficacy of montelukast in the treatment of asthma has been demonstrated in numerous controlled clinical trials. The aim of this study was to assess the real-life effectiveness of montelukast administered as monotherapy or in combinati
Autor:
James A. Scott, Bruce P. Lanphear, Stuart E. Turvey, Malcolm R. Sears, Ryan Allen, Tim K. Takaro, Michael Brauer, Allan Becker, Amanda J. Wheeler, Kathleen E. McLean, Jeffrey R. Brook, Piush J. Mandhane, Padmaja Subbarao
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background Exposure to tobacco smoke increases the risk for several adverse health effects in children including wheeze, asthma, and asthma exacerbation. Accurately assessing tobacco smoke exposure is important for understanding and preventing these
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 7, Iss 1, p 13 (2011)
Department of Medicine Publications
Allergy, Asthma & Clinical Immunology, Vol 7, Iss 1, p 13 (2011)
Department of Medicine Publications
Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents available for the treatment of asthma and represent the mainstay of therapy for most patients with the disease. Although these medications are considered safe at low-to-mo